These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 28443249

  • 1. Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models.
    Caspar Y, Maurin M.
    Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    Caspar Y, Hennebique A, Maurin M.
    J Antimicrob Chemother; 2018 Mar 01; 73(3):687-691. PubMed ID: 29253157
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey.
    Yesilyurt M, Kiliç S, Celebi B, Celik M, Gül S, Erdogan F, Ozel G.
    J Antimicrob Chemother; 2011 Nov 01; 66(11):2588-92. PubMed ID: 21856791
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    Tomaso H, Hotzel H, Otto P, Myrtennäs K, Forsman M.
    J Antimicrob Chemother; 2017 Sep 01; 72(9):2539-2543. PubMed ID: 28605439
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
    Kiliç S, Celebi B, Acar B, Ataş M.
    Scand J Infect Dis; 2013 May 01; 45(5):337-41. PubMed ID: 23249114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [In Vitro Activity of Tigecycline Against Francisella tularensis Subsp. holarctica in Comparison with Doxycycline, Ciprofloxacin and Aminoglycosides].
    Ulu Kılıç A, Kılıç S, Celebi B, Sencan I.
    Mikrobiyol Bul; 2013 Jan 01; 47(1):189-91. PubMed ID: 23390918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe.
    Kreizinger Z, Makrai L, Helyes G, Magyar T, Erdélyi K, Gyuranecz M.
    J Antimicrob Chemother; 2013 Feb 01; 68(2):370-3. PubMed ID: 23065699
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure.
    Sutera V, Hoarau G, Renesto P, Caspar Y, Maurin M.
    Int J Antimicrob Agents; 2017 Sep 01; 50(3):377-383. PubMed ID: 28689870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New therapeutic approaches for treatment of tularaemia: a review.
    Boisset S, Caspar Y, Sutera V, Maurin M.
    Front Cell Infect Microbiol; 2014 Sep 01; 4():40. PubMed ID: 24734221
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013.
    Origgi FC, Frey J, Pilo P.
    Euro Surveill; 2014 Jul 24; 19(29):. PubMed ID: 25080140
    [Abstract] [Full Text] [Related]

  • 18. Septic pneumonic tularaemia caused by Francisella tularensis subsp. holarctica biovar II.
    Fritzsch J, Splettstoesser WD.
    J Med Microbiol; 2010 Sep 24; 59(Pt 9):1123-1125. PubMed ID: 20522628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.